With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients EP News Bureau Dec 2, 2022 Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
Gilead, Novo Nordisk expand NASH clinical collaboration EP News Bureau Mar 18, 2021 Triple combination regimen to be investigated in new Phase 2b study in NASH patients with cirrhosis
UK researchers find semaglutide could be a ‘game changer’ drug to fight obesity Press Trust of India Feb 13, 2021 The drug, semaglutide, works by hijacking the body's own appetite-regulating system in the brain leading to reduced hunger and…
